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. Surveys of the marine environment have resulted in an estimated prevalence of 10 30 phages in the oceans alone, meaning that for each bacterial cell in the ocean there are ~10 phages 1 . In addition to their abundance within the marine environment 2 , phages are prevalent within the soil 3, 4 and in freshwater 5 . Phages have even been isolated from some of the most inhospitable conditions, including desert sands 6 , sea ice 7 and the depths of the ocean 8 . In addition to our surroundings, phages are abundant in and on plants 9 and within the bodies of insects and mammals 10, 11 . Indeed, the human gut alone is home to an estimated 2 trillion phages 12 , greatly exceeding the number of eukaryotic viruses in our bodies 13 . Although phages are unable to infect eukaryotic cells, evidence has been reported of direct interactions, such as direct transcytosis of phages across cell layers of the gut, lung, liver, kidney and brain 14 , between phages and human cells 14, 15 . However, the full extent of direct and indirect effects of phages is unknown as researchers have only just begun to speculate about the roles of phages in the human body, including the human immune and central nervous systems 12 .
As phage genomes can be double-stranded DNA (dsDNA), single-stranded DNA (ssDNA), doublestranded RNA (dsRNA) or single-stranded RNA (ssRNA), linear or circular and even segmented, sequencing phage populations often is limited by the genomic nucleic acid extraction protocol and might require amplification before sequencing 16 . Amplification can introduce biases such as quantitative biases, the preferential amplification of ssDNA viruses, stochastic biases and systemic biases [17] [18] [19] . Nevertheless, whole-genome sequencing technologies have enabled researchers to identify new phage species. In contrast to cellular organisms, no universal marker exists for phages because no gene is conserved within all phages. To identify phages, researchers often target genes that encode structural proteins such as phylogenetic markers 20 . However, these signature sequences are far from comprehensive 21 . Only a small fraction of phage sequence diversity is represented in extant sequence databases, and it is heavily biased for sequences of phages with DNA genomes that infect bacterial species that are routinely studied in the laboratory, such as Escherichia coli, Pseudomonas spp. and Bacillus spp. [22] [23] [24] . Metagenomics, the high-throughput sequencing of mixed, complex communities of microorganisms,
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has enabled exploration of the diversity of phages on Earth 2-5 and the human body [25] [26] [27] [28] [29] [30] [31] , including in the lower urinary tract [32] [33] [34] [35] [36] . The Human Microbiome Project (HMP), which characterized human microbiota using 16S ribosomal RNA gene sequencing and metagenomic whole-genome shotgun sequencing, revolutionized our understanding of bacteria that inhabit the human body 37 . However, the bladder was not included in the HMP publications, which focused on the oral cavity, nasal cavity, skin, gastrointestinal tract and vagina 37, 38 . In the absence of a urinary tract infection (UTI), the bladder was thought to be sterile; therefore, it was not included in the HMP 39 . This dogma resulted, in part, from the widespread use of standard clinical microbiology urine culture protocols, which are designed to detect common fast-growing pathogens with basic nutrient needs and no aversion to oxygen (especially E. coli). Thus, the standard protocol does not detect anaerobes, slow-growing bacteria or bacteria with complex needs. However, diverse bacterial and fungal species have been detected in urine obtained directly from the bladder via transurethral catheterization (herein catheterization) or suprapubic aspiration that is negative using standard culture using an enhanced urine culture method called expanded quantitative urine culture (EQUC) and/or DNA sequencing methods, such as Lactobacillus, Corynebacterium, Streptococcus, Actinomyces, Staphylococcus, Aerococcus, Gardnerella, Saccharomyces and Candida spp. [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] . These and other studies of the bladder microbiome and microbiota have revealed associations of bladder bacteria with postoperative UTIs 50, 51 , urgency urinary incontinence (UUI) 44, 45, 47 and response to overactive bladder (OAB) treatment 52 . For instance, the microbiome of women with UUI had increased levels of Gardnerella spp. and decreased Lactobacillus spp. relative to the microbiome of women without UUI 44 . Some bacteria are even associated with the lack of symptoms, and an abundance of Lactobacillus iners seems to provide protection against post-instrumentation UTI 46, 50, 51, 53, 54 . These results suggest that the bladder might possess its own protective microbiota and that dysbiosis results in disorders, such as UTI and UUI 55, 56 . An effort to generate a genomic catalogue of bacteria isolated from the bladder that was published in 2018 revealed that the genomes of bladder bacteria are quite distinct from bacteria isolated from the gut but are somewhat similar to those of the vagina 57 . This observation suggests an interlinked female urogenital microbiota; that is, strains resident in the vaginal community could be transferred to the urinary tract and vice versa.
Although the HMP focused on characterizing the bacterial fraction of the human microbiota, sequencing of some viral genomes was unavoidable because viral DNA was present in the samples and because prophage DNA (a stage in the lysogenic cycle when the phage genome either integrates into the host genome or remains in the cytoplasm as a self-replicating plasmid) was present within the bacteria 58 . Subsequent to the original initiative, bacterial and viral communities within the five niches studied in the HMP were extensively investigated 59 , most notably the communities inhabiting the gastrointestinal tract as it is a high biomass niche and can be studied using stool samples as a proxy. These viral communities include both eukaryotic viruses and phages. The gut virome (the viral component of the microbiome) has been the focus of numerous studies [25] [26] [27] [28] [29] [30] [31] , each leading to the same conclusion: phages are key members of the gut microbiota. A core phage community exists within the gut of healthy individuals 30 , and disruption of this core phage community (dysbiosis) has been associated with certain gastrointestinal symptoms and disease, such as Crohn's disease and ulcerative colitis 27, [29] [30] [31] 60, 61 . Within the gut, seven phage taxa were found to be associated with type 2 diabetes, establishing a type 2 diabetes-specific gut phage community 62 . Other studies have characterized the viromes of the body sites included in the HMP [63] [64] [65] [66] [67] [68] ; the data from these studies are publicly available (Table 1 ). Similar to the gut, associations between phage communities and patient symptoms and/or disease have been identified in these other body sites. For example, phages within the oral cavity have been linked to periodontitis 65 . These associations within the gut and oral cavity are active areas of investigation as the extent to which phages modulate the human microbiota remains an open question. Furthermore, phage communities and their putative role in disease and/or symptoms have yet to be determined in the other niches studied within the HMP. Although the investigation of the urinary microbiota was launched independent of and subsequent to the HMP, considerable progress has been made in characterizing this niche. Investigations into the phages of the lower urinary tract present challenges unique to this niche but have greatly benefited from the work of their predecessors exploring the viromes of the five HMP niches.
Studies of the bacterial communities of the lower urinary tract in both women and men have revealed a diverse community of species. Furthermore, studies of the urinary microbiome have documented the clinical relevance of bladder bacteria, including associations with urinary symptom levels, treatment response and UTI risk 42, 44, 45, [51] [52] [53] [54] [69] [70] [71] [72] . Phages are the most abundant biological entities in the human body, and given observations made in other organs, phages are probably vital members of the lower urinary tract microbiota with the potential contribution to urinary symptoms and/or disease. Their role in the lower urinary tract is largely unknown. In this Review, we describe the current knowledge of phages within the urinary tract and their possible contribution to urinary tract health. We provide
Key points
• Bacteriophages (phages) are abundant members of the microbiota of the lower urinary tract.
• Active or lytic phages have been isolated from urine samples, but the majority of phages within the urinary microbiota persist through dormant infections, the lysogenic life cycle.
• evidence suggests that phages have a role in modulating the composition of the urinary microbiota, similar to that observed in microbiota of other organs of the human body.
• Phage therapy, or the use of phages to treat pathogenic bacterial infections, is an active area of research within urology given their potential use to treat urinary tract infections.
a brief introduction to phages followed by a discussion of both culture-based and culture-independent studies of the viruses of the urinary tract. We present some of the challenges in studying the urinary microbiota. Finally, we consider the clinical relevance and applications of phages. Both historical and current applications of phage therapy for lower UTIs and other disorders are discussed.
The phage life cycle Phages have three distinct, generally well-characterized life cycles for propagation and reproduction: lytic, lysogenic and chronic 72 . All phages infect their bacterial host by binding to surface receptors, a process called adsorption (Fig. 1) ; these receptor-binding proteins are often quite specific, leading to a narrow range of hosts (strains or species) that a particular phage can infect 73 . Following adsorption into the host cell, the phage injects its DNA or RNA genome into the host's cytoplasm. In the lytic cycle, the phage genome replicates and phage proteins are synthesized 74 . For dsDNA phages, DNA is inserted into the protein procapsid, whereas for ssDNA and ssRNA phages, the capsid is formed around the nucleic acid (Fig. 1) . The bacterium's cell wall breaks ('bursts'); phage proteins called holins can form holes in the cytoplasmic membrane or spanins can degrade the outer membrane 74 , and the phage progeny disperse into the surrounding environment. Some phages are obligately lytic, but others, called temperate phages, can alternate between the lysogenic and lytic cycles. In the lysogenic cycle, the phage genome either integrates into the host genome or remains in the cytoplasm as a selfreplicating plasmid 75 ( Fig. 1) . The phage genome (now called a prophage) generally replicates in synchrony with the host chromosome; some phage genes are also known to be expressed by the bacterium 75 . Temperate phages, such as the model phage λ, are capable of going through the lytic and lysogenic cycles. Prophages can remain dormant for generations until, often, an environmental cue (such as host starvation or changes in nutrients or temperature 75, 76 ) triggers entry into the lytic cyclea process known as induction. This switch between the lysogenic and lytic cycle can also be determined by the phage-produced peptide communication system (called the arbitrium system), in which progeny phage lysogenize when this peptide is abundant within the environment 77 . In addition to the lytic and lysogenic cycles, phages can reproduce by chronic infection; in this process, phages (for example, the filamentous phage M13) are shed from the bacterial cell without killing the host cell 78 . The majority of known phages can be associated with one of these three life cycles, but additional modes of infection and reproduction, such as pseudolysogeny, have been described 72, 76, 78 . Given these multiple mechanisms of infection and persistence, unsurprisingly phages can have profound effects on microbial communities (Fig. 1) . Phages can transform a microbial community through predation (lysis) [79] [80] [81] . Furthermore, phages can affect bacterial diversity within a community [82] [83] [84] [85] , including adaptation in susceptible host species such as loci associated with phage resistance 86, 87 . Co-evolving lytic phages can increase diversity within bacterial populations by selecting for multiple modes of resistance 84 . Phages have also been shown to alter apparent competition among bacterial strains 84 . Exposure to temperate phages can increase bacterial virulence (a process referred to as lysogenic conversion) 88, 89 by, for example, encoding toxins 90, 91 . Case reports detail Shiga-toxin-producing E. coli strains, most commonly associated with enteric infections, found within the urine of individuals with UTIs [92] [93] [94] . In this example, the Shiga toxin is carried by a phage integrated within the E. coli genome. Thus, lysogeny can be beneficial for the bacterial host 95 . Some temperate phages can transfer genetic material from one cell to another (the process of transduction (Fig. 2) ) because they integrate their genome into their host's genome; this process can benefit the recipient host cell. Indeed, temperate phages are well known to mediate horizontal gene transfer (HGT) and have helped spread virulence and/or resistance factors through bacterial communities 96 . Similarly, lytic phages can transfer bacterial DNA via transduction 97 . Data exist that support both frequent and infrequent phage-mediated spread of antibiotic resistance genes [98] [99] [100] [101] . Phages also can contribute to HGT indirectly; for example, a 2017 study identified two 'superspreader' phages, which are phages that promote extensive plasmid transformation 102 . In this scenario, phage lysis spreads intact host plasmids, enabling HGT via transformation. The two superspreader phages discovered were 50 times more efficient in dispersing antibiotic resistance genes 102 . Given the large genetic diversity present within phage communities 103 , investigation of the complexities of phage-host dynamics is in very early stages 22, 31, 104, 105 .
Viruses of the urinary tract
Viruses are abundant members of the human microbiota, found throughout the body including the uri nary tract. These viruses include those that infect human cells (eukaryotic viruses) as well as both lytic and lysogenic phages. 
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Eukaryotic viruses. The urinary tract harbours a diverse eukaryotic viral community, including adenoviruses, anelloviruses, papillomaviruses and polyomaviruses [32] [33] [34] [35] [36] [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] [116] . Adenoviruses can be detected in urine 106 and can range from limited, localized infections in otherwise healthy individuals to severe and potentially fatal infections in immunocompromised individuals 107 . Torque teno virus (TTV), also referred to as small anellovirus, has largely been studied in relation to immunodeficiency in renal transplant recipients 108 . Rani et al. 32 collected midstream clean-catch urine from 22 kidney transplant recipients; whole-genome sequencing was conducted for the urinary viromes of these samples and 108 different subtypes of TTV were detected. The most prevalent eukaryotic viruses in urine samples are human polyomavirus 1 (BK virus) and 2 (JC virus) 109 . Both of these polyomaviruses seem to have little effect on healthy individuals, but each can lead to nephropathy and haemorrhagic cystitis in immunocompromised populations 110, 111 . Metagenomic sequencing of the bladder microbiome (both the bacterial and viral fractions) of 30 individuals enabled reconstruction of the full JC virus genome in five of the samples 33 . JC virus and other polyomaviruses have also been detected in other viromes from urine samples (obtained using an undescribed voided urine collection method) 34 . Human papillomaviruses (HPVs) have also been detected in voided urine 112 and bladder tissue 113, 114 . Certain HPV genotypes have been attributed to condyloma acuminatum of the bladder 115, 116 , but these high-risk genotypes associated with cervical cancer are rare. In one investigation of the urinary virome, 95% of the 20 participants sampled had HPV sequences detected in their urine 35 ; for 8 patients, these samples were collected via intermittent catheterization and for the others, an undescribed voided urine collection method was used. In the case of the latter, whether contamination from either the skin microbiota or the vaginal microbiota, both of which are known to contain HPV 117 , occurred is unknown. However, eukaryotic viruses are estimated to represent just a small fraction of the urinary virome [33] [34] [35] [36] . Lytic phages. Lytic phages have been isolated directly from urine on numerous occasions. The first phage from urine was isolated by the co-discoverer of bacteriophages Félix d'Hérelle in 1917 when he observed that this invisible microorganism lysed the Shiga bacillus, despite not knowing exactly what a phage was at the time 118 . A century later, two studies isolated phages capable of infecting Pseudomonas aeruginosa from urine samples 119, 120 . Transmission electron microscopy (TEM) of the isolated phages provided information about the phages' morphology, which includes a siphophage (a tailed phage with a long, thin, often flexible tail structure 119 ) and two tailless phages 120 (Fig. 3) . A fourth Pseudomonas-infecting phage, harvested from a bacterial isolate from a urine sample collected via catheterization, has been discovered (G. Johnson and C.P., manuscript in preparation). This phage is capable of lysing P. aeruginosa PAO1. Coliphages, or phages that infect E. coli, have also been isolated from voided and catheterized urine samples. Dallas and Kingsbery 121 found 100,000 colony-forming units (CFU)/ml of bacterial growth in routinely plated urine samples (collected using an unknown method) and, upon closer inspection, phage plaques. Furthermore, four coliphages were isolated from clinical urine samples, and their morphologies were determined to be siphophages using TEM 119 . A further seven coliphages were isolated from the bladder of four women with UUI (in urine collected via catheterization) 122 . From the complete genomes of these seven coliphages, six (phages Greed, Sloth, Envy, Pride, Gluttony and Lust) resemble coliphages that were isolated from cattle slurry 123 . This observation of similarity suggests that the human urinary virome might include strains found within other hosts and could have a regulatory role in the urinary microbiota. The seventh coliphage identified, phage Wrath, most closely resembles a lysogenic Bacillus phage sequence. TEM images suggested that these phages had siphophage morphology (Fig. 4) . Testing the host range of the phage Greed showed that in addition to its ability to lyse the laboratory strains E. coli C and K-12, it is also capable of infecting and lysing some E. coli strains isolated from urine samples, including the uropathogen E. coli CFT073 (reF.
).
Thus, within the urinary microbiota, Greed might be effective in thwarting the proliferation of uropathogenic E. coli strains. However, the lytic phage population is only one part of the phage community within the lower urinary tract.
Lysogenic phages. Lysogenic phage communities have been routinely under-reported in the human body, a direct result of the methods used to collect and sequence viral isolates 125 . In fact, evidence suggests that lysogenic phages are the most abundant phage type within the gut microbial community 126 . Similar observations have been made within the bladder. Several prophages have been identified within E. coli isolates collected from catheterized urine from the bladder 127 . Numerous prophage sequences have been identified within the genomes of four Gardnerella strains isolated from urine specimens obtained via catheterization from the bladders of adult women with UUI, although a lytic Gardnerella-infecting phage has yet to be isolated, possibly owing to the challenges of growing this phage in the laboratory 128 . Analysis of these four genomes and other publicly available Gardnerella genomes revealed that phage infections were pervasive within the urinary microbiota 128 . This examination of lysogenic phages was then expanded to include 181 bacterial isolates, which was representative of the phylogenetic diversity within the bladder 129 . These samples were collected from women with or without lower urinary tract symptoms. Over 400 phage sequences were identified; the majority (86%) of these bacterial isolates harboured one or more lysogenic phages 129 . Furthermore, many (57%) of the phages identified in this study 129 exhibited no sequence similarity to any known phages, indicative of a vast unexplored phage population residing in the bladder.
To date, three published studies have used a metagenomic approach to sequence the viral fraction of the urinary microbiota. The first study, conducted by Santiago-Rodriguez and colleagues 35 , sought to determine whether the urinary virome was affected by urinary tract health status. The viral fraction (eukaryotic viruses and extracellular phages) of urine collected from ten individuals with and ten individuals without a diagnosed UTI were sequenced. For each cohort, samples were collected either via catheterization or voided urine from five men and five women. As previous research has shown, clean-catch studies of voided urine from women routinely contain bacterial taxa from vaginal contamination 41 . Furthermore, the bacterial taxa of the male and female urinary microbiota are not identical 130, 131 . Only 27% of the viral sequences produced in this study were homologous to known viruses, the majority (>99%) of which represented phage genes 35 , again suggesting a large unexplored phage community within the urinary tract. In a second study, urine samples were collected via the voided midstream clean-catch method from 14 men and 8 women who received a kidney transplant 32 , and the viral fraction was isolated and sequenced. Phages are present in these viromes, but this study did not mention phages and sequence data are not publicly available; instead, the authors focused solely on eukaryotic viruses 132 . The subsequent study by Thannesberger et al. 34 also found a large phage community, but the authors concluded that the phage community primarily consisted of relatives of known species, the majority resembling Chlamydia microviruses, which infect Chlamydia spp. This study included two healthy individuals and four individuals with human cytomegalovirus (CMV) infections. However, information about how the urine was collected or the demographics of the patients was not provided. This omission, compounded by the small sample size, limits our ability to frame the study's results with respect to other virome studies.
Viral diversity within the urinary tract has also been studied by sequencing the entire urinary microbiota. 
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In 2018, Moustafa et al. 36 published a study in which metagenomic sequencing was performed for urine samples from 49 individuals with suspected UTIs (collected via the clean-catch method). As this study did not select for the viral fraction, most of the sequenced data corresponded to bacterial genetic material. Nevertheless, viral -primarily phage -sequences were detected 36 . Similar to the study conducted by Santiago-Rodriguez and colleagues 35 , this study examined samples from individuals with UTIs and detected sequences homologous to those from phages that infect bacteria commonly found within the urinary tract and associated with UTIs, including those of the genera Escherichia, Enterococcus, Lactobacillus and Pseudomonas 36 . Abundant bacterial species harbouring prophages would result in an abundance of phages; thus, one would expect to identify phages infectious of UTI-associated bacterial taxa. In a similar approach, sequencing was undertaken of urine collected using catheterization from 10 asymptomatic women and 20 women with OAB 33 . Partial and complete viral genomes were reconstructed in 12 of the 30 samples sequenced, including the complete genomes of novel phage strains 33 . Partial and complete phage genomes also exhibited sequence homology to previously characterized lytic or lysogenic phages that infect Gardnerella, Lactobacillus and Streptococcus species. These bacterial species are dominant members of the urinary microbiota of healthy women as well as women with OAB 44 ; thus, one would expect to readily identify phage infection of these taxa. In sequencing both the bacterial and viral members of the microbiota, associations between phages and their hosts can be inferred. As both of these studies have highlighted, phages that infect dominant bacterial taxa within the urinary microbiota can be identified 33, 36 . One can, therefore, postulate that novel phage sequences (phages that do not share sequence homology with any known, sequenced phage or prophage sequence) are infectious of a bacterial taxa within that same individual's urinary microbiota, whereas more prolific phage species, which are representative of more deeply sequenced viral sequences, are probably infectious of dominant bacterial taxa.
Culture-based and culture-independent studies have revealed a large, active phage population within the lower urinary tract. The diversity present has yet to be comprehensively catalogued, but the consistent finding that the majority of phage sequences detected do not resemble known, sequenced phages suggests a novel community within the urinary tract. In parallel to continued efforts to catalogue this community, future studies should conduct comparisons of the urinary virome with the viromes of other areas of the human body. In particular, comparisons with the gut virome are warranted given emerging evidence that viruses of the gut have been found elsewhere in the body 12 .
Challenges of studying bladder phages
The bladder has orders of magnitude less microbial bio mass than the gastrointestinal tract, oral cavity or vagina 43, 133, 134 . DNA concentrations are often low, a challenge faced by both those studying the bacterial constituents and those investigating the viral constituents of the bladder 135 . Thus, two of the metagenomic studies of the urinary virome used amplification before sequencing 34, 35 . This technique is efficient for increasing viral genomic material, but these amplification methods have well-documented biases [17] [18] [19] . For instance, multiple displacement amplification (MDA) can increase the DNA template concentration for sequencing, but small circular viral genomes are overamplified. Both MDA and sequence-independent, single-primer amplification (SISPA) methods have also been found to underamplify viral genomes with GC contents at the extremes 18 . Perhaps of greater concern are the methods by which urine is collected and the anatomical microbiota that the collected urine represents. The method of urine collection is a frequently debated and investigated topic in the field 55, 130, 135 owing to the need to balance the invasiveness of procedures during collection and the purity of the sample obtained. This debate is not unique to the bladder, urinary tract or urine; biopsy and stool samples give quantitatively and qualitatively different results for the gut 136 , and methods of sampling the gut microbiota are still being refined 137, 138 . Studies of voided urine have routinely observed vaginal contamination of clean-catch samples 36, 48 . Virome studies by Santiago-Rodriguez and colleagues 35 , Rani and colleagues 32 and Moustafa and colleagues 36 investigated voided urine samples. Thus, whether the viruses detected resided in the bladder and/or in the urethra, vagina or skin remains unknown. Another study, in which the bacterial communities in the bladder were obtained via paired samples by catheterization and suprapubic aspiration from women were compared, showed that both methods did not isolate microbial communities that resembled the skin or vaginal microbiomes and successfully avoided vulvovaginal contaminants 41 . Moreover, the communities identified by the two methods were similar 41 . Although a similar study has not been conducted comparing the virome of 
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NAtUre reviews | UrOLOGy urines collected via catheterization and suprapubic aspiration, one would assume that both represent the same community of the bladder microbiome. Thus, catheterized urine samples have a lower probability of contaminants than voided urine samples 127 . Study of less-invasive methods for collection is an ongoing pursuit 139 . In a 2019 study, the use of the non-invasive Peezy midstream device (Forte Medical) was tested 140 . The results showed that voided urine collected by the Peezy was less prone to contamination than samples collected using the cleancatch midstream method, having a bacterial abundance distinct from the periurethra 140 . This device is a promising step towards a sampling method that is less invasive than catheterization, which is the current best method for sampling the bladder's microbiota.
Phages and urinary tract health
The associations between phage communities, bacterial populations and the human host are not yet fully understood. Some evidence suggests that phages might contribute to human health 141 , in particular in the gut, where phages have been suggested to have roles including maintaining a stable bacterial community and providing an innate defence to pathogenic species 27, [29] [30] [31] 60 . These studies of the gut will probably inform future studies of the urinary tract and other niches of the human body, providing a model for conducting such studies and expanding our knowledge of phage genetic diversity within the human body. Paralleling those discoveries of associations between phage communities of the gut and gastrointestinal symptoms, associations have also been made within the bladder: variation was observed in the abundance of lysogenic phages in bacteria isolated from asymptomatic individuals and those with OAB, in which the microbiota of women with OAB included more Lactobacillus phages than the microbiota of women without OAB 129 . However, notably, the Lactobacillus species between these two cohorts varied, which might be contributing to the observed difference and, therefore, warrants further investigation 129 .
Variation, determined via the β-diversity statistic and principal component analysis, was not found in the extracellular phage populations of individuals with or without UTI symptoms 35 . Although the bacterial communities differ between individuals with and without UTIs, the virome does not seem to change in response, suggesting that UTI symptoms are not associated with changes in the virome 35 . Further investigation of this observation is needed as the sample size was limited. However, importantly, understanding of the diversity of phages within the urinary tract has only just begun, in contrast to the gut phage communities. Cataloguing the phage community in both asymptomatic and symptomatic individuals is a critical first step in understanding whether and how phages contribute to urinary tract health. All of the aforementioned studies discovered a large collection of novel viral sequences indicative of a unique genetic diversity present within the urinary tract. Further investigation of phage-bacteria dynamics in the bladder and urinary tract could reveal indicators for early detection of symptoms.
Phages could also offer a defence to the human host against pathogenic bacteria. Studies of the gut communities have revealed unexpected ways in which phages interact with human cells, organs and the immune system 12, 29 . The prevalence of phages on the mucosal surfaces of the gut might confer a direct benefit to the human host by protecting the epithelium from bacteria 142 . This study's findings suggest that phages and mucosal surfaces have co-evolved such that phages bind to mucosal glycoproteins; this phage mucosal layer reduces adherence of bacterial pathogens 142 . Changes in the mucosal phage population have been associated with ulcerative colitis 61 . Evidence also suggests that phages have increased virulence to bacteria when human cells are present 143 . In this study, phages were found to reduce Clostridium difficile numbers more efficiently in the presence of human cells 143 . Furthermore, phages can interact directly with human cells. Studies have found that the wild-type T4 phage and its substrain HAP1 can bind to cancer cell membranes and inhibit or attenuate melanoma tumour growth 144 . Although phages cannot infect eukaryotic cells, there are several means in which they can enter eukaryotic cells. A phage could be a passenger, as a cell of an invasive bacterial species that harbours a phage could enter a eukaryotic cell 145, 146 . Alternatively, eukaryotic cells can take up free phages by endocytosis 145, 147 . A Staphylococcus-infecting phage was capable of infecting bovine mammary epithelial cells and clearing intracellular Staphylococcus aureus 147 . One study showed that phages are capable of penetrating epithelial cell layers via endocytosis, with an estimated 31 billion phage particles passing through these layers of the gut into the body daily 14 . Given this observation, in a study of the urinary virome, comparison with the gut virome should be considered in order to identify whether urinary phages originated from the gut. Within the human body, phages can modulate immune responses 148 . For instance, T4 phages mediated inhibition of T cell proliferation via the CD3 complex 149 in vitro and stimulated humoral responses in mice in vitro and in vivo 150 . Phage-mediated immunoregulation holds promise, such as for attenuating the expression of pro-inflammatory cytokines during UTIs 151 . The mechanisms by which phages interact with the immune system remain an active area of investigation 148 . Appreciation is growing for the therapeutic potential of modulating the human microbiome. Induction and release of temperate phages can lyse sensitive competitor strains or lysogenize other cells 152, 153 . For instance, the gut bacterium Enterococcus faecalis, which has also been associated with UTIs, uses its prophages to colonize when competing strains are present 152 . Alternatively, an individual's bacterial infection can be treated with obligately lytic phages, known as phage therapy. In the face of the increasing threat of antibiotic-resistant bacterial strains, phage therapy has regained interest 154 . Phage therapy was a promising area of UTI treatment in the early 20th century. For instance, in a 1928 report, phages isolated from sewage were 90% efficient in lysing E. coli and P. aeruginosa strains isolated from catheterized urine samples 155 . The USA and Western Europe abandoned phage therapy when antibiotics became commercially available (among other reasons) 156 ; this area of research and treatment continued in Eastern European countries. Phage therapy is a publicly available treatment for individuals with UTIs in Russia, Poland and the Democratic Republic of Georgia. In one study 157 , 41 E. coli and 9 Klebsiella pneumoniae strains isolated from individuals with UTI were challenged with phages from collections from the Democratic Republic of Georgia. Only one E. coli isolate was resistant to the individual phages and phage cocktails tested, and one phage was capable of lysing all K. pneumoniae strains. Similar efficiencies have been observed for other bacterial species that cause UTI symptoms. A single patient, for whom gentamicin, ceftazidime, ciprofloxacin and meropenem were unable to clear the root cause of the UTI (P. aeruginosa) for >2 years, was successfully treated with a combination of six phages from the Eliava Institute in Tbilisi (Georgia) collection 158 . Phage treatment was administered via catheterization every 12 h for 10 days, meropenem was administered starting on day 6 through day 30 and urine samples were negative 1 year later 158 . A 2-year-long clinical trial of bacteriophages for treating UTI in patients undergoing transurethral resection of the prostate (NCT03140085) at the Tsulukidze National Center of Urology (Tbilisi, Georgia) concluded in 2017. Participants were treated with an antibiotic, a phage (bacteriophage Pyo and adapted substrains of Pyo) or a placebo; the latter two were administered via catheterization for 7 days 159, 160 . The study was unable to draw any statistically reliable conclusions, but it did conclude that phage treatment of UTIs might be effective and safe 161 . Phages have also been explored for their potential use in pretreating long-term catheters to minimize bacterial biofilm development and catheter blockage, which can cause catheter-associated UTIs (CAUTIs) 162 . Catheters have been pretreated with phages that infect P. aeruginosa 163 164 and E. coli 165 with varied success. The pretreatment of catheters with two phages was found to considerably reduce P. mirabilis biofilms for up to 168 h post-treatment 164 .
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Increased understanding of phage, microbiota and human host interactions is imperative for the feasibility of phage therapy of urinary tract symptoms and infections. Phage therapy has the potential to combat antibiotic-resistant bacterial infections, and anecdotal evidence of its success certainly warrants further investigation 166 . Phage therapy has already proved effective in the treatment of bacterial infections in other areas of the human body. In the highly publicized case of a life-threatening Acinetobacter baumannii infection, all modern antibiotics were found to be ineffective and >100 phages were tested before the few phages capable of saving the patient's life were found 167 . Phage-drug cocktails are promising as well; for instance, such a cocktail was used to clear a vascular graft P. aeruginosa infection 168 . The Pseudomonas phage OMKO1, used in combination with ceftazidime, was able to completely clear the infection as bacteria resistant to the phage were more sensitive to ceftazidime and vice versa 168 . All phages infect their bacterial host by binding to surface receptors, a process called adsorption (Fig. 1) ; these receptor-binding proteins are often quite specific, leading to a narrow range of hosts (strains or species) that a particular phage can infect 73 . This specificity is in direct contrast to broad-spectrum antibiotics and has the benefit of targeting the pathogen with no effect against commensal bacteria. However, this specificity means that phage therapeutics will probably have to be developed on a patient-by-patient basis. In the aforementioned A. baumannii case, >100 A. baumannii phages (selected from a larger collection of phages known to infect multidrug-resistant A. baumannii strains) were screened against clinical isolates from the patient; the vast majority of the phages tested had no effect against the clinical isolates 167 . A phage therapy effective for a larger patient population (n > 1) will, therefore, probably be a cocktail of phages, including phages capable of infecting different strains. Phage cocktails also provide the benefit of outpacing pathogen evolution, a strategy similar to that used for the vascular graft infection 168 . Given the rise of antibiotic resistance, phage therapy is a promising replacement or augmentation to antibiotic treatment for infections throughout the body, including infections of the urinary tract. Several clinical trials are or have been conducted, including the recent trial for UTIs 160, 161 , the results of which provide critical data for moving forward.
Conclusions
Whole-genome sequencing and new enhanced culture methods have been of great benefit to the study of the microorganisms within the bladder and the rest of the lower urinary tract, but considerable work remains to be done. An ongoing debate is occurring surrounding the potential presence of vulvovaginal and/or skin bacterial contaminants in urine samples of the urinary microbiota, and the same conversation is relevant to the new study of the lower urinary tract virome. Most of the studies discussed herein, with a few exceptions 33, 122, 128, 129 , have used voided urine for isolation of lytic phages or sequencing of the urinary virome. To the best of our knowledge, the phage populations of adjacent anatomical locations have yet to be investigated; therefore, the rate of incidence of viral contamination is unknown. As we have just begun to explore the phage communities within the urinary tract, such considerations must be kept in mind. More samples of the urinary virome must be sequenced to determine whether, as in the gut 30 , a core phage community exists within the bladder, the urethra, the periurethral niche and adjacent urogenital niches. Only through such efforts can we fully ascertain what comprises a healthy and an unhealthy phage community. Whether a shift from the lysogenic life cycle to the lytic cycle is a cause or consequence of bacterial community dysbiosis or urinary symptoms is currently unknown. Studies such as those by Moustafa et al. 36 and Garretto et al. 33 will be particularly powerful in capturing the dynamics between phages and their hosts, increasing understanding of their interactions. These studies should become increasingly attainable as the costs of sequencing continue to decline.
Knowledge of the phage communities within the lower urinary tract and their role in urinary tract health is a vital first step in the development of new strategies to treat urinary symptoms and infections. However, critical to effective and reliable phage therapy strategies is the understanding of the extant beneficial microbiota. Phage therapies should ideally cause minimal to no disturbance of this community. In contrast to broad-spectrum antibiotics, phages can be directed very narrowly towards a specific pathogen within the community. Given the observed novelty of many of the phages sequenced from urine and from the bladder 35, 129 , perhaps the genomes of the modifiers of urinary tract health have already been sequenced. Our understanding of the phage population of the urinary tract is in its infancy, and future studies will highlight new areas of investigation.
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